MYC and stroke disorder: The most promising approach appears to be fusion of the conditional immortalized C-MYC gene (avian myelocytomatosis viral oncogene homolog) with a mutated estrogen receptor, leading to the CTX0E03 human NSC line [32], which showed efficacy in promoting behavioral recovery in stroke patients [33].